Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
29.24
Dollar change
+0.12
Percentage change
0.41
%
IndexRUT P/E- EPS (ttm)-6.33 Insider Own2.58% Shs Outstand55.95M Perf Week-3.31%
Market Cap1.64B Forward P/E- EPS next Y-5.87 Insider Trans-12.67% Shs Float54.74M Perf Month-13.16%
Income-352.09M PEG- EPS next Q-1.64 Inst Own107.20% Short Float12.51% Perf Quarter28.08%
Sales26.82M P/S61.26 EPS this Y-5.19% Inst Trans-3.01% Short Ratio8.08 Perf Half Y19.18%
Book/sh14.50 P/B2.02 EPS next Y11.81% ROA-32.36% Short Interest6.85M Perf Year29.67%
Cash/sh13.83 P/C2.11 EPS next 5Y39.00% ROE-36.83% 52W Range19.80 - 35.50 Perf YTD31.30%
Dividend Est.- P/FCF- EPS past 5Y-0.98% ROI-40.56% 52W High-17.63% Beta0.82
Dividend TTM- Quick Ratio11.99 Sales past 5Y2.66% Gross Margin44.95% 52W Low47.71% ATR (14)1.14
Dividend Ex-Date- Current Ratio12.27 EPS Y/Y TTM-49.22% Oper. Margin-1459.52% RSI (14)48.29 Volatility3.01% 3.58%
Employees383 Debt/Eq0.09 Sales Y/Y TTM88.36% Profit Margin-1312.63% Recom1.67 Target Price40.67
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q-358.63% Payout- Rel Volume0.51 Prev Close29.12
Sales Surprise-10.38% EPS Surprise-3.77% Sales Q/Q64.80% EarningsFeb 15 BMO Avg Volume847.89K Price29.24
SMA20-4.23% SMA506.59% SMA20015.57% Trades Volume434,786 Change0.41%
Date Action Analyst Rating Change Price Target Change
Feb-08-24Initiated Cantor Fitzgerald Overweight
Feb-03-23Initiated Piper Sandler Overweight $41
Nov-17-22Upgrade Goldman Sell → Neutral $17 → $32
Jul-27-22Upgrade SVB Leerink Mkt Perform → Outperform $33
Dec-03-21Initiated BofA Securities Buy $54
Jul-30-21Downgrade Goldman Neutral → Sell $58 → $39
Jul-01-21Initiated Raymond James Mkt Perform
Jun-10-21Initiated H.C. Wainwright Buy $88
Mar-01-21Upgrade SVB Leerink Mkt Perform → Outperform $50
Mar-01-21Downgrade JP Morgan Overweight → Neutral $64 → $54
Mar-05-24 07:00AM
Feb-26-24 03:12PM
Feb-23-24 10:45AM
Feb-22-24 07:00AM
Feb-20-24 08:24AM
09:38AM Loading…
Feb-16-24 09:38AM
Feb-15-24 10:15PM
08:25AM
07:59AM
07:00AM
Feb-08-24 10:00AM
Feb-02-24 07:00AM
Jan-24-24 07:02PM
Jan-11-24 07:15PM
Jan-08-24 07:00AM
11:19AM Loading…
Jan-04-24 11:19AM
07:47AM
Jan-03-24 04:05PM
02:46PM
02:01PM
10:09AM
09:26AM
06:58AM
06:40AM
06:30AM
Jan-02-24 07:00AM
Dec-09-23 07:00PM
Nov-21-23 10:56AM
Nov-20-23 07:00AM
Nov-03-23 12:10PM
11:06AM Loading…
11:06AM
Nov-02-23 09:32AM
09:05AM
07:10AM
07:00AM
Oct-19-23 07:00AM
Sep-07-23 11:30AM
Aug-29-23 07:00AM
Aug-10-23 06:08AM
Aug-04-23 05:32PM
09:10AM
06:04AM
Aug-03-23 11:53PM
07:55AM
06:54AM
06:35AM
06:30AM
Jul-18-23 09:55AM
Jul-17-23 09:55AM
Jul-13-23 07:00AM
Jun-28-23 09:40AM
Jun-27-23 01:47PM
Jun-26-23 02:23PM
06:30AM
Jun-12-23 09:55AM
Jun-05-23 07:00AM
May-30-23 09:45AM
May-25-23 09:55AM
07:00AM
May-11-23 10:00AM
May-09-23 09:55AM
May-08-23 07:55AM
May-05-23 10:50AM
May-04-23 11:23PM
08:25AM
07:00AM
Apr-25-23 07:00AM
Apr-19-23 07:00AM
Apr-13-23 07:00AM
Apr-12-23 08:00AM
Apr-09-23 01:19PM
Apr-03-23 07:00AM
Mar-15-23 11:44AM
Mar-11-23 09:10AM
Mar-05-23 05:20AM
Mar-02-23 08:26AM
Feb-28-23 07:00AM
Feb-24-23 12:00PM
11:49AM
Feb-23-23 08:45AM
08:38AM
07:00AM
Feb-09-23 09:40AM
Feb-02-23 07:00AM
Jan-15-23 08:56AM
Jan-08-23 08:00PM
Jan-03-23 05:57PM
Dec-24-22 10:07AM
Dec-21-22 08:00AM
Dec-11-22 07:00PM
Dec-10-22 06:30PM
Dec-06-22 07:00AM
Nov-30-22 08:00AM
Nov-17-22 05:52AM
Nov-11-22 11:03AM
Nov-10-22 04:01PM
Nov-09-22 05:36AM
Nov-04-22 12:20PM
Nov-03-22 09:00AM
08:25AM
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foster-Cheek Kaye IDirectorMar 07 '24Sale31.621,28540,6325,524Mar 11 04:09 PM
Foster-Cheek Kaye IDirectorMar 06 '24Sale31.994,415141,2366,809Mar 07 06:49 PM
Goff BrianChief Executive OfficerMar 05 '24Sale32.574,156135,36153,780Mar 05 04:10 PM
Burns James WilliamChief Legal OfficerMar 05 '24Sale32.572,64286,05034,518Mar 05 04:08 PM
Gheuens SarahChief Medical OfficerMar 05 '24Sale32.572,64286,05036,415Mar 05 04:20 PM
Washburn Theodore James Jr.Principal Accounting OfficerMar 05 '24Sale31.751,91360,7382,886Mar 07 06:47 PM
Washburn Theodore James Jr.Principal Accounting OfficerMar 05 '24Sale32.571,21439,5403,368Mar 05 04:15 PM
Jones CeciliaChief Financial OfficerMar 05 '24Sale32.5767221,88714,840Mar 05 04:18 PM
Foster-Cheek Kaye IDirectorMar 05 '24Sale32.213009,66311,224Mar 07 06:49 PM
Washburn Theodore James Jr.Principal Accounting OfficerMar 01 '24Option Exercise0.003,12705,718Mar 05 04:15 PM
Goff BrianChief Executive OfficerMar 01 '24Option Exercise0.008,500057,936Mar 05 04:10 PM
Burns James WilliamChief Legal OfficerMar 01 '24Option Exercise0.007,834038,518Mar 05 04:08 PM
Gheuens SarahChief Medical OfficerMar 01 '24Option Exercise0.007,834040,415Mar 05 04:20 PM
Jones CeciliaChief Financial OfficerMar 01 '24Option Exercise0.002,000015,512Mar 05 04:18 PM
Schenkein David PDirectorFeb 27 '24Option Exercise31.6469,3292,193,570180,325Feb 29 04:05 PM
Schenkein David PDirectorFeb 27 '24Sale34.6769,3292,403,592122,854Feb 29 04:05 PM
Schenkein David PDirectorFeb 26 '24Option Exercise31.6420,411645,804143,265Feb 27 04:04 PM
Schenkein David PDirectorFeb 26 '24Sale33.1920,411677,441122,854Feb 27 04:04 PM
Schenkein David PDirectorFeb 23 '24Option Exercise31.6447,7311,510,209170,585Feb 27 04:04 PM
Schenkein David PDirectorFeb 23 '24Sale33.0547,7311,577,510122,854Feb 27 04:04 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 20 '24Sale26.6350413,4222,741Feb 22 05:43 PM
Gheuens SarahChief Medical OfficerFeb 14 '24Sale25.1464216,14033,431Feb 14 05:53 PM
Burns James WilliamChief Legal OfficerFeb 14 '24Sale25.1454513,70131,666Feb 14 05:51 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 14 '24Sale25.142736,8633,245Feb 14 05:50 PM
Washburn Theodore James Jr.Principal Accounting OfficerFeb 12 '24Option Exercise0.0077703,518Feb 14 05:50 PM
Gheuens SarahChief Medical OfficerFeb 12 '24Option Exercise0.002,162034,073Feb 14 05:53 PM
Burns James WilliamChief Legal OfficerFeb 12 '24Option Exercise0.001,833032,211Feb 14 05:51 PM
FOUSE JACQUALYN ADirectorJan 24 '24Sale21.6410,722232,024129,253Jan 24 04:22 PM
Goff BrianChief Executive OfficerJan 24 '24Sale21.647,635165,22149,436Jan 24 04:20 PM
Jones CeciliaChief Financial OfficerJan 24 '24Sale21.641,88640,81313,069Jan 24 04:23 PM
Burns James WilliamChief Legal OfficerJan 24 '24Sale21.641,70836,96130,378Jan 24 04:25 PM
Gheuens SarahChief Medical OfficerJan 24 '24Sale21.641,70836,96131,911Jan 24 04:24 PM
Milanova TsvetaChief Commercial OfficerJan 24 '24Sale21.641,61835,01413,234Jan 24 04:19 PM
Gheuens SarahChief Medical OfficerJan 20 '24Option Exercise0.005,750033,619Jan 24 04:24 PM
Jones CeciliaChief Financial OfficerJan 20 '24Option Exercise0.005,380014,955Jan 24 04:23 PM
FOUSE JACQUALYN ADirectorJan 20 '24Option Exercise0.0023,9000139,975Jan 24 04:22 PM
Milanova TsvetaChief Commercial OfficerJan 20 '24Option Exercise0.005,448014,852Jan 24 04:19 PM
Goff BrianChief Executive OfficerJan 20 '24Option Exercise0.0017,018057,071Jan 24 04:20 PM
Burns James WilliamChief Legal OfficerJan 20 '24Option Exercise0.005,750032,086Jan 24 04:25 PM
Goff BrianChief Executive OfficerJan 09 '24Sale22.9912,066277,39740,053Jan 09 04:28 PM
FOUSE JACQUALYN ADirectorJan 09 '24Sale22.998,391192,909116,075Jan 09 04:26 PM
Gheuens SarahChief Medical OfficerJan 09 '24Sale22.991,78941,12927,869Jan 09 04:22 PM
Burns James WilliamChief Legal OfficerJan 09 '24Sale22.991,16326,73726,336Jan 09 04:25 PM
Burns James WilliamChief Legal OfficerJan 05 '24Option Exercise0.003,250027,499Jan 09 04:25 PM
Gheuens SarahChief Medical OfficerJan 05 '24Option Exercise0.005,000029,658Jan 09 04:22 PM
Goff BrianChief Executive OfficerJan 05 '24Option Exercise0.0025,527052,119Jan 09 04:28 PM
FOUSE JACQUALYN ADirectorJan 05 '24Option Exercise0.0017,5000124,466Jan 09 04:26 PM
Milanova TsvetaChief Commercial OfficerJan 05 '24Sale22.322,90264,7739,404Jan 05 04:10 PM
Milanova TsvetaChief Commercial OfficerJan 03 '24Option Exercise0.008,475012,306Jan 05 04:10 PM
Jones CeciliaChief Financial OfficerSep 28 '23Sale24.792,17954,0179,575Sep 28 04:02 PM
Jones CeciliaChief Financial OfficerSep 26 '23Option Exercise0.007,472011,754Sep 28 04:02 PM
Burns James WilliamChief Legal OfficerAug 17 '23Sale26.286,395168,06123,890Aug 21 04:03 PM
Ballal Rahul D.DirectorAug 11 '23Option Exercise0.002,30202,302Aug 15 04:06 PM
Smith CynthiaDirectorAug 11 '23Option Exercise0.002,30202,302Aug 15 04:04 PM
Foster-Cheek Kaye IDirectorAug 09 '23Option Exercise18.0925,000452,25036,524Aug 11 04:04 PM
Foster-Cheek Kaye IDirectorAug 09 '23Sale25.9625,000648,88811,524Aug 11 04:04 PM
Goff BrianChief Executive OfficerAug 08 '23Option Exercise0.0022,691036,770Aug 10 04:07 PM
Goff BrianChief Executive OfficerAug 08 '23Sale25.4810,178259,33526,592Aug 10 04:07 PM
Washburn Theodore James Jr.Principal Accounting OfficerAug 07 '23Sale25.392,91874,0962,741Aug 09 04:04 PM
Washburn Theodore James Jr.Principal Accounting OfficerAug 01 '23Option Exercise0.004,15006,891Aug 02 04:02 PM
Washburn Theodore James Jr.Principal Accounting OfficerAug 01 '23Sale26.261,23232,3525,659Aug 02 04:02 PM
Goff BrianChief Executive OfficerJun 30 '23Sale28.3611,449324,69414,079Jun 30 04:05 PM
FOUSE JACQUALYN ADirectorJun 30 '23Sale28.3610,718303,962106,966Jun 30 04:07 PM
Burns James WilliamChief Legal OfficerJun 30 '23Sale28.361,70748,41130,285Jun 30 04:09 PM
Gheuens SarahChief Medical OfficerJun 30 '23Sale28.361,70748,41124,159Jun 30 04:06 PM
Milanova TsvetaChief Commercial OfficerJun 30 '23Sale28.361,61845,8863,831Jun 30 04:02 PM
Jones CeciliaChief Financial OfficerJun 30 '23Sale28.361,59745,2913,783Jun 30 04:03 PM
Jones CeciliaChief Financial OfficerJun 28 '23Option Exercise0.005,38005,380Jun 30 04:03 PM
Milanova TsvetaChief Commercial OfficerJun 28 '23Option Exercise0.005,44905,449Jun 30 04:02 PM
FOUSE JACQUALYN ADirectorJun 28 '23Option Exercise0.0023,9000117,684Jun 30 04:07 PM
Goff BrianChief Executive OfficerJun 28 '23Option Exercise0.0025,528025,528Jun 30 04:05 PM
Gheuens SarahChief Medical OfficerJun 28 '23Option Exercise0.005,750025,866Jun 30 04:06 PM
Burns James WilliamChief Legal OfficerJun 28 '23Option Exercise0.005,750031,992Jun 30 04:09 PM
Schenkein David PDirectorJun 21 '23Option Exercise0.004,9750122,854Jun 23 04:34 PM
Foster-Cheek Kaye IDirectorJun 21 '23Option Exercise0.004,975011,524Jun 23 04:38 PM
Ho MaykinDirectorJun 21 '23Option Exercise0.004,975011,524Jun 23 04:37 PM
Scadden DavidDirectorJun 21 '23Option Exercise0.004,975012,095Jun 23 04:36 PM
FOUSE JACQUALYN ADirectorApr 08 '23Option Exercise0.0015,933098,515Apr 12 04:17 PM
Schenkein David PDirectorApr 03 '23Option Exercise9.0516,363148,085134,242Apr 05 04:03 PM
Schenkein David PDirectorApr 03 '23Sale22.8516,363373,895117,879Apr 05 04:03 PM